(Q75221014)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14704792%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

title

Priming of naive T cells inside tumors leads to eradication of established tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14704792%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14704792%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

author name string

Ping Yu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14704792%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Youjin Lee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14704792%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Wenhua Liu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14704792%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Robert K Chin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14704792%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Jing Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14704792%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Yang Wang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14704792%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Andrea Schietinger

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14704792%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Mary Philip

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14704792%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Hans Schreiber

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14704792%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

publication date

4 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14704792%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14704792%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14704792%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14704792%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

page(s)

141-149

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14704792%20AND%20SRC:MED&resulttype=core&format=json

Human tumor antigens recognized by T lymphocytes

17 November 2019

cites work

1 reference

7 January 2021

A new era for cancer immunotherapy based on the genes that encode cancer antigens

1 reference

7 January 2021

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

1 reference

7 January 2021

Strategies for designing and optimizing new generation vaccines

1 reference

7 January 2021

Spinning molecular immunology into successful immunotherapy

1 reference

7 January 2021

CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy

1 reference

7 January 2021

NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway

1 reference

7 January 2021

Immune surveillance against a solid tumor fails because of immunological ignorance

1 reference

7 January 2021

Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells

1 reference

7 January 2021

Animals bearing malignant grafts reject normal grafts that express through gene transfer the same antigen

1 reference

7 January 2021

Cytotoxic T lymphocytes to an unmutated tumor rejection antigen P1A: normal development but restrained effector function in vivo.

1 reference

7 January 2021

Antigenic Cancer Cells Grow Progressively in Immune Hosts without Evidence for T Cell Exhaustion or Systemic Anergy

1 reference

7 January 2021

Eradication of established tumors by CD8+ T cell adoptive immunotherapy

1 reference

7 January 2021

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

1 reference

7 January 2021

Progress in the development of immunotherapy for the treatment of patients with cancer

1 reference

7 January 2021

LIGHT, a New Member of the TNF Superfamily, and Lymphotoxin α Are Ligands for Herpesvirus Entry Mediator

1 reference

7 January 2021

Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen

1 reference

7 January 2021

The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function

1 reference

7 January 2021

Role for CCR7 ligands in the emigration of newly generated T lymphocytes from the neonatal thymus

1 reference

7 January 2021

Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization

1 reference

7 January 2021

Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway

1 reference

7 January 2021

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

7 January 2021

CD28/B7 system of T cell costimulation

1 reference

7 January 2021

Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

1 reference

7 January 2021

Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family

1 reference

7 January 2021

A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation

1 reference

7 January 2021

Development and maturation of secondary lymphoid tissues.

1 reference

7 January 2021

Chemokines and cell migration in secondary lymphoid organs

1 reference

7 January 2021

Mig and IP-10: CXC chemokines that target lymphocytes

1 reference

7 January 2021

Signaling via LTbetaR on the lamina propria stromal cells of the gut is required for IgA production

1 reference

7 January 2021

Complementary role of CD4+ T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8+ T cells.

1 reference

7 January 2021

Lineage relationship and protective immunity of memory CD8 T cell subsets

1 reference

7 January 2021

Immunological ignorance of silent antigens as an explanation of tumor evasion

1 reference

7 January 2021

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

1 reference

7 January 2021

Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells

1 reference

7 January 2021

Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue

1 reference

7 January 2021

Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo

1 reference

7 January 2021

SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10

1 reference

7 January 2021

LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer

1 reference

7 January 2021

Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth

1 reference

7 January 2021

Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines

1 reference

7 January 2021

Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells

1 reference

7 January 2021

B cells control the migration of a subset of dendritic cells into B cell follicles via CXC chemokine ligand 13 in a lymphotoxin-dependent fashion

1 reference

7 January 2021

The requirement of membrane lymphotoxin for the presence of dendritic cells in lymphoid tissues

1 reference

7 January 2021

Identifiers

DOI

10.1038/NI1029

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14704792%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1 reference